Oral Nutritional Supplement in Type 2 Diabetes Subjects With or at Risk of Malnutrition

Lifestyle Control of Postprandial Hyperglycemia

NCT02683135 ·Status: COMPLETED ·Phase: NA

Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

NCT05985135 ·Status: NOT_YET_RECRUITING ·Phase: NA

Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

NCT01663220 ·Status: COMPLETED

The Acute Effects of Low-dose TNF-α on Glucose Metabolism and β-cell Function in Humans

NCT01953393 ·Status: COMPLETED ·Phase: NA

Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

NCT00544206 ·Status: COMPLETED ·Phase: PHASE2

GLP-1 and Oxyntomodulin Release in Relation to Diet in Type 2 Diabetes Patients.

NCT04105608 ·Status: COMPLETED ·Phase: NA

Delineation of the Role of Glucagon-like Peptide-1 Signalling in Relation to Increased Carbohydrate Content in the Distal Small Intestines

NCT03241303 ·Status: COMPLETED ·Phase: NA

Incretin Hormones in Type 1 Diabetes Mellitus;Effect of Metformin Treatment

NCT04177303 ·Status: UNKNOWN ·Phase: PHASE3

A Study to Determine Iatrogenic Hyperinsulinemia's Contribution to Insulin Resistance and Endothelial Dysfunction in Type 1 Diabetes

NCT04118374 ·Status: COMPLETED ·Phase: NA

Group Lifestyle Intervention for People With New Onset Type 2 Diabetes.

NCT00705952 ·Status: COMPLETED ·Phase: NA

GA 6: The Blood Glucose-lowering Effect of Glucose-dependent Insulinotropic Polypeptide

NCT03845179 ·Status: COMPLETED ·Phase: NA

Resolution of Type 2 Diabetes Mellitus: Intensive vs. Conventional Glycaemic Control After Obesity Surgery

NCT01257087 ·Status: COMPLETED ·Phase: NA

The Role of GLP-1 Receptor Signalling in the Glucose-lowering Effect of Metformin in Patients With T2D

NCT03246451 ·Status: COMPLETED ·Phase: NA

Effects of a Small Protein and Lipid Preload on Glucose Tolerance in Subjects With Impaired Glucose Homeostasis

NCT02342834 ·Status: COMPLETED ·Phase: NA

To Determine Tolerability to Glucagon Infusion in Obese Subjects

NCT02817659 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

NCT02592421 ·Status: COMPLETED ·Phase: PHASE3

Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Healthy Subjects

NCT01454973 ·Status: COMPLETED

Glucolipotoxicity and Type 2 Diabetes

NCT01375270 ·Status: COMPLETED ·Phase: NA

Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects

NCT03139305 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH)

NCT04616014 ·Status: COMPLETED ·Phase: PHASE2

Study TO Prevent Diabetes With Short-term Insulin Glargine Only

NCT01276912 ·Status: UNKNOWN ·Phase: NA

Normalization of Fasting Glucose and the Incidence of Restenosis After Peripheral Angioplasty

NCT01150617 ·Status: TERMINATED ·Phase: PHASE4

Sustained Effects of a Non-glucidic Nutrient Preload on Glucose Tolerance in Type 2 Diabetes

NCT02477761 ·Status: UNKNOWN ·Phase: NA

Acute Effect of Intensive Insulin Infusion on Intestinal Triglyceride-rich-lipoprotein-apoB48 Metabolism in Type 2 Diabetic Patients

NCT00950209 ·Status: COMPLETED ·Phase: NA

Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment

NCT00795600 ·Status: COMPLETED ·Phase: PHASE4